SCHEMBL2227288

SCHEMBL2227288

C#CCOC1C(O)[C@@H](CO)O[C@H]1n1cnc2c(O)ncnc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.53
▸ ADORA3 P0DMS8 3/20 0.52
▸ SLC29A1 Q99808 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ DPP4 P27487 1/20 0.52
▸ SLC28A1 O00337 1/20 0.52
▸ MAP3K7 O43318 1/20 0.52
▸ SLC28A2 O43868 1/20 0.52
▸ GAPDH P04406 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ STAT6 P42226 1/20 0.52
▸ PI4KA P42356 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ PI4K2B Q8TCG2 1/20 0.52
▸ DOT1L Q8TEK3 1/20 0.52
▸ PI4K2A Q9BTU6 1/20 0.52
▸ SLC28A3 Q9HAS3 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14916257 1.00 ADORA1 (0.53) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL22333908 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL29498967 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL1061068 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL28991007 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL1061070 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL28569675 0.89 ADORA3 (0.68) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL3437117 0.89 ADORA1 (0.56) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL29771414 0.84 ADORA1 (0.56) ADORA1ADORA3SLC29A1MEN1KMT2A
SCHEMBL1059414 0.84 ADORA1 (0.56) ADORA1ADORA3SLC29A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160348109-A1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY SIRNA THERAPEUTICS INC (US) 2016-12-01 — — US disclosed
US-9441228-B2 Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistry SIRNA THERAPEUTICS, INC. (US) 2016-09-13 — — US disclosed
EP-2526113-B1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY SIRNA THERAPEUTICS INC (US) 2016-08-10 — — EP disclosed
US-20150211008-A1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY BANK OF AMERICA, N.A. 2015-07-30 — — US disclosed
US-20130116419-A1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY SIRNA THERAPEUTICS, INC. 2013-05-09 — — US disclosed
WO-2011090968-A1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY MERCK SHARP & DOHME CORP. (US) 2011-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116419-A1 POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA \"CLICK\" CHEMISTRY RTCB, SNRPB2, STAU1 ADORA1 2130/4885ADORA3 1725/4885SLC29A1 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback